How Peptides Interact with Receptors: A Primer

The Lock-and-Key Model

Peptide-receptor interactions follow the fundamental principle of molecular recognition: a peptide (the key) binds to a receptor protein (the lock) through complementary shape, charge, and hydrophobic interactions. When the correct peptide binds, it triggers a conformational change in the receptor that initiates intracellular signaling — converting an extracellular chemical signal into a biological response.

Binding Affinity

Binding affinity describes how tightly a peptide binds to its receptor, expressed as a dissociation constant (Kd). A lower Kd means tighter binding. For biologically active peptides, Kd values typically range from picomolar (extremely tight) to micromolar (moderate). Affinity determines the concentration of peptide needed to produce a biological effect — higher affinity means lower concentrations are effective.

Selectivity

Selectivity describes a peptide's preference for one receptor over others. A highly selective peptide activates its target receptor at concentrations far below those needed to affect other receptors. Selectivity is critical for interpreting research results — a non-selective peptide may produce effects through multiple pathways, complicating the attribution of observed changes to a specific mechanism.

Agonists vs Antagonists

Agonists bind to a receptor and activate it, mimicking the natural ligand. GLP-1 receptor agonists, for example, bind to and activate the GLP-1 receptor just as natural GLP-1 does.

Antagonists bind to a receptor but do not activate it — instead, they block the natural ligand from binding. Antagonist peptides are valuable research tools for determining what happens when a specific receptor pathway is blocked.

Partial agonists activate a receptor but produce a submaximal response even at saturating concentrations, offering a middle ground between full activation and blockade.

Structure-Activity Relationships

The relationship between a peptide's structure and its biological activity is studied through systematic modification of the amino acid sequence. Replacing individual amino acids and measuring the effect on binding and activation reveals which residues are critical for receptor interaction. This SAR data guides the design of optimized peptide analogs with improved potency, selectivity, or stability.